Avril has acquired Sunbloom Proteins, a German company specializing in sunflower proteins, to strengthen its position in the global plant-based protein market.
Information on the Target
Sunbloom Proteins is a German company established in 2017, which has emerged as a specialist in the production and marketing of sunflower proteins intended for human consumption. The firm, founded by leveraging the research innovations of the esteemed Fraunhofer-Gesellschaft based in Munich, employs a workforce of 35 and operates an industrial facility in Hungary. Its core offerings involve the application of a distinct patented process, allowing the company to create protein concentrates that excel in functional, organoleptic, and nutritional quality derived from sunflower seeds.
Sunbloom Proteins stands out in the marketplace by utilizing non-allergenic and non-GMO sunflower seeds sourced within Europe. The company’s products are designed to cater to varying consumer and industry needs, hence providing sustainable protein sources that address diverse segments such as ready meals, vegetable drinks, desserts, bakery products, and sports nutrition.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
The plant-based protein market in Germany has seen significant growth in recent years, driven by a rising consumer preference for healthier and more sustainable food options. This shift reflects broader global trends focusing on plant-based d
Similar Deals
O3 Holding GmbH (KD Pharma Group) → food-grade oil business from dsm-firmenich
2025
Freudenberg Home and Cleaning Solutions → Marigold Household Gloves business
2013
Avril
invested in
Sunbloom Proteins
in
in a Other deal